Technological and Patent Evolution of Murine Monoclonal Antibodies
Kátia dos Reis, José Procópio Moreno Senna, Nei Pereira Júnior & Maria Antonieta Peixoto Gimenes Couto · Journal of Advances in Biology & Biotechnology · 2017
Among the pharmaceutical products targeted for patent protection, monoclonal antibodies stand out. Technological advances involving monoclonal antibodies aim to minimize detrimental human immune responses to antibodies (e.g., human anti-murine antibodies [HAMA]) and increase the...
Open access
Research Article
10.9734/JABB/2017/34759